Metagenomi Therapeutics, Inc. Common Stock — Quarterly Financial Statements (NASDAQ:MGX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Market Capitalization 56.5081 M
Employee 124
Founded 2016
CEO N/A
Website metagenomi.co
Headquarter California, United States
FIGI BBG00Y5ZXS77
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

56.51 M Market capitalization

Price to earnings ratio

-1.11

Price to sales ratio

2.74

Dividends per share

—

Dividend yield %

—

Noticias

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates